lobbying_activities: 1629003

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1629003	794fd321-6fed-40ec-835e-39890a672aec	Q4	EISAI INC.	400321512	EISAI INC.	2014	fourth_quarter	PHA	DEA Scheduling of Controlled Substances H.R. 4299 -- Improving Regulatory Transparency for New Medical Therapies Act S. 2862 -- Transparency, Patient Access and Effective Drug Enforcement Act of 2014	HOUSE OF REPRESENTATIVES,SENATE		500000	0	0	2015-01-19T11:13:31.920000-05:00